BioMar posts 14% Q2 sales volume growth, raises earnings guidance.
Aquafeed producer BioMar reported a 14% year-on-year increase in sales volumes for the second quarter, with contributions from all feed segments, maintaining earnings momentum from its record year in 2024.
Q2 EBITDA was DKK 349 million ($55.8 million), down from DKK 361 million ($57.8 million) a year earlier, reflecting a shift in customer mix toward large-volume buyers. Non-consolidated joint ventures in China and Turkey generated EBITDA of DKK 48 million ($7.7 million), compared with DKK 64 million ($10.2 million) in Q2 2024.
Return on invested capital including goodwill was 19.6% at 30 June, slightly below 19.8% a year earlier. Operating cash flow rose to DKK 249 million ($39.8 million) from DKK 116 million ($18.6 million), aided by cash management initiatives.
BioMar now expects full-year 2025 revenue of DKK 16.3–17.0 billion ($2.61–2.72 billion), up from prior guidance of DKK 16.0–17.0 billion ($2.56–2.72 billion), and has raised its EBITDA forecast to DKK 1,490–1,570 million ($238.4–251.2 million) from DKK 1,470–1,570 million ($235.2–251.2 million).
CEO Carlos Diaz said the company was “on track” for a good full-year result, citing healthy profitability, improved cash flow and continued investment in customer partnerships.
